HIGH WYCOMBE, England, September 8 /PRNewswire/ -- Janssen-Cilag / Ortho Biotech, the biopharmaceutical division of Janssen-Cilag, today announced the European Commission's approval of VELCADE in combination with melphalan and prednisone for the ...
Original post: VELCADE(R) (Black Triangle Drug) (bortezomib) Approved For Previously ... - Yahoo Finance
- Recent posts
- Analysts not concerned about Apple's stock option irregularities - Mac Central
- Smoking may Sabotage Chronic Pain Management
- Pediatric Pain Management Alternatives for Nurses and Students
- Why do Pain Management doctors prescribe Xanax?
- F5 Networks Integration With Microsoft Offerings Delivers Optimum IT ... - Consumer Electronics Net
- Pot smoker sues for getting dismissed from pain management center
- VELCADE(R) (Black Triangle Drug) (bortezomib) Approved For Previously ... - Yahoo Finance
- Communication gap between health care professionals and pain patients - HULIQ.com
- Pain Flare Up Planning for More Effective Chronic Pain Management
- Physical therapy can help reduce pain - Pottstown Mercury
- Pain management involves more than injections - NWI.com
- Significant’ findings into lower back pain - This is Southampton
- Pain management, Oprah-style
- Tiffany D. Soares Inducted into Cambridge Who's Who Executive ... - 24-7PressRelease.com
- Laboring longer a growing trend for Americans - Detroit News
- Pain management involves more than injections - NWITimes.com
- WESTERN WASHINGTON PAIN MANAGEMENT! #082808251
- Nurses Accurately Assess Pain In Children, Research Shows - Medical News Today
- Seminar on Pain Management - Sept. 20, 2008
- Bragging Writes - Marion Chronicle-Tribune